Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-announces-positive-phase-III-results-showing-efficacy-of-BAF312-in-patients-with-secondar-22951511/?utm_source=whatsapp&utm_medium=social&utm_campaign=share